Enalapril Viatris 5 mg comprimidos EFG clinical trials

Phase 2, multicenter, randomized, open-label, controlled, 2-arm cross-over study to evaluate the clinical efficacy and safety of a renin inhibitor, aliskiren, compared to an angiotensin converting enzyme inhibitor, enalapril, in children and adults with C3 glomerulopathy

This study is looking at two medicines, aliskiren and enalapril, for people with a rare kidney disease called C3 glomerulopathy. We want to see how well they work to protect your kidneys and if they are safe. It involves taking both medicines at different times.